摘要
目的研究分析经子宫动脉途径介入治疗子宫切口妊娠的临床效果.方法将2016年1月-2017年1月我科室收治的子宫切口妊娠的患者89例为本次研究对象,对照组采用药物治疗,观察组患者采用经子宫动脉途径介入治疗,比较两组患者的治疗情况以及血清β-人绒毛膜促性腺激素(Serum beta-human chorionic gonadotropin,β-HCG)水平.结果观察组患者术中出血量、住院时间、血β-HCG恢复正常时间、孕酮恢复正常时间、月经恢复正常时间与对照组比较均不同程度的减少,差异有统计学意义(P<0.05).经治疗后,两组患者的血β-HCG水平均不同程度下降,观察组患者下降幅度小于对照组,差异有统计学意义(P<0.05).结论经子宫动脉途径介入治疗子宫切口妊娠具有较好临床应用价值,能够减少患者术中出血量,缩短患者住院时间,促进月经、孕酮以及血β-HCG水平的尽快恢复,促进患者尽快康复.
Objective To study the clinical effect of interventional therapy of uterine incision pregnancy via uterine artery. Methods Eighty-nine patients with uterine incision pregnancy admitted to our department from January 2016 to January 2017 were enrolled in this study. The control group was treated with drug therapy. The observation group was treated with interventional therapy via uterine artery. The treatment state and serum β-human chorionic gonadotropin (β-HCG) was compared. Results The amount of intraoperative blood loss, length of hospital stay, normal time of blood β-HCG recovery, normal time of progesterone recovery, and normal time of menstrual recovery in observation group were significantly different from those in the control group, P < 0.05. After treatment, the level of blood β-HCG of the two groups were decreased to different extents. The decrease extent of the observation group was smaller than that of the control group, P < 0.05. Conclusion Interventional therapy of uterine incision pregnancy via uterine artery has good clinical value, it can reduce the amount of intraoperative blood loss, shorten the length of hospital stay, promote the recovery of menstrual, progesterone and blood β-HCG levels, and promote the recovery of patients as soon as possible .
作者
申景欣
SHEN Jingxin(Department of Obstetrics and Gynecology,Changsha Central Hospital Affiliated to Nanhua University,Changsha Hu’nan 410011,China)
出处
《中国卫生标准管理》
2019年第13期37-40,共4页
China Health Standard Management
关键词
经子宫动脉
介入治疗
子宫切口妊娠
出血量
Β-人绒毛膜促性腺激素
临床疗效
via uterine artery
interventional therapy
uterine incision pregnancy
bleeding volume
β-human chorionic gonadotropin
clinical efficacy